The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
María del Carmen Rodríguez‐Salazar(Universidad Autónoma de Nuevo León), Cristina Rodrı́guez-Padilla(Universidad Autónoma de Nuevo León)
Cited by 26
Related Papers
IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model
|Biomedicine & Pharmacotherapy|2020|25
β-D-Glucose-Reduced Silver Nanoparticles Remodel the Tumor Microenvironment in a Murine Model of Triple-Negative Breast Cancer
|International Journal of Molecular Sciences|2024|3